{"created":"2023-06-19T07:25:30.857435+00:00","id":13374,"links":{},"metadata":{"_buckets":{"deposit":"ca1f8ee0-5f93-416e-820d-69697676d10c"},"_deposit":{"created_by":55,"id":"13374","owners":[55],"pid":{"revision_id":0,"type":"depid","value":"13374"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013374","sets":["212:263:303"]},"author_link":["20302","20304","20307","20300","20301","20306","20303","20305"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"365","bibliographicPageStart":"362","bibliographicVolumeNumber":"150","bibliographic_titles":[{"bibliographic_title":"Can Pharm J (Ott)"}]}]},"item_3_text_4":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_text_value":"10.1177/1715163517732088"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer."}]},"item_type_id":"3","owner":"55","path":["303"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-07-30"},"publish_date":"2018-07-30","publish_status":"0","recid":"13374","relation_version_is_last":true,"title":["Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer."],"weko_creator_id":"55","weko_shared_id":-1},"updated":"2023-06-19T08:56:23.658104+00:00"}